Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Víctor Faundes is active.

Publication


Featured researches published by Víctor Faundes.


Clinical Chemistry | 2016

Identification of Males with Cryptic Fragile X Alleles by Methylation-Specific Quantitative Melt Analysis

Solange Aliaga; Howard R. Slater; David Francis; Desirée du Sart; Xin Li; David J. Amor; Angélica Alliende; Lorena Santa María; Víctor Faundes; Paulina Morales; César Trigo; Isabel Salas; Bianca Curotto; David E. Godler

BACKGROUND FMR1 full mutations (FMs) (CGG expansion >200) in males mosaic for a normal (<45 CGG) or gray-zone (GZ) (45-54 CGG) allele can be missed with the standard 2-step fragile X syndrome (FXS) testing protocols, largely because the first-line PCR tests showing a normal or GZ allele are not reflexed to the second-line test that can detect FM. METHODS We used methylation-specific quantitative melt analysis (MS-QMA) to determine the prevalence of cryptic FM alleles in 2 independent cohorts of male patients (994 from Chile and 2392 from Australia) referred for FXS testing from 2006 to 2013. All MS-QMA-positive cases were retested with commercial triplet primed PCR, methylation-sensitive Southern blot, and a methylation-specific EpiTYPER-based test. RESULTS All 38 FMs detected with the standard 2-step protocol were detected with MS-QMA. However, MS-QMA identified methylation mosaicism in an additional 15% and 11% of patients in the Chilean and Australian cohorts, respectively, suggesting the presence of a cryptic FM. Of these additional patients, 57% were confirmed to carry cryptic expanded alleles in blood, buccal mucosa, or saliva samples. Further confirmation was provided by identifying premutation (CGG 55-199) alleles in mothers of probands with methylation-sensitive Southern blot. Neurocognitive assessments showed that low-level mosaicism for cryptic FM alleles was associated with cognitive impairment or autism. CONCLUSIONS A substantial number of mosaic FM males who have cognitive impairment or autism are not diagnosed with the currently recommended 2-step testing protocol and can be identified with MS-QMA as a first-line test.


Neurologia | 2017

Aspectos clínicos, moleculares y farmacológicos en los trastornos asociados a gen 1 del retraso mental del X frágil

Ángela Pugin; Víctor Faundes; L. Santa María; Bianca Curotto; Solange Aliaga; Isabel Salas; Paula Soto; Paulina Bravo; M.I. Peña; María Angélica Alliende

BACKGROUND Fragile X syndrome, the most common inherited cause of intellectual disability, is associated with a broad spectrum of disorders across different generations of a single family. This study reviews the clinical manifestations of fragile X-associated disorders as well as the spectrum of mutations of the fragile X mental retardation 1 gene (FMR1) and the neurobiology of the fragile X mental retardation protein (FMRP), and also provides an overview of the potential therapeutic targets and genetic counselling. DEVELOPMENT This disorder is caused by expansion of the CGG repeat (>200 repeats) in the 5 prime untranslated region of FMR1, resulting in a deficit or absence of FMRP. FMRP is an RNA-binding protein that regulates the translation of several genes that are important in synaptic plasticity and dendritic maturation. It is believed that CGG repeat expansions in the premutation range (55 to 200 repeats) elicit an increase in mRNA levels of FMR1, which may cause neuronal toxicity. These changes manifest clinically as developmental problems such as autism and learning disabilities as well as neurodegenerative diseases including fragile X-associated tremor/ataxia syndrome (FXTAS). CONCLUSIONS Advances in identifying the molecular basis of fragile X syndrome may help us understand the causes of neuropsychiatric disorders, and they will probably contribute to development of new and specific treatments.


Medicina Clinica | 2012

Genética de la sordera congénita

Víctor Faundes; Rosa Pardo; Silvia Castillo Taucher

Congenital deafness is defined as the hearing loss which is present at birth and, consequently, before speech development. It is the most prevalent sensor neural disorder in developed countries, and its incidence is estimated between 1-3 children per 1,000 newborns, of which more than 50% are attributable to genetics causes. Deafness can be classified as syndromic or non-syndromic. In the first case, it is associated with outer ear malformations and/or systemic findings. More than 400 syndromes accompanied of deafness have been described, which represent about 30% of cases of congenital hearing loss. The remaining percentage corresponds to non-syndromic cases: 75-85% are autosomal recessive, 15-24% are autosomal dominant, and 1-2% are X-linked. The evaluation of a child with deafness requires a multidisciplinary collaboration among specialists, who must coordinate themselves and give information to the affected family. The aims of establishing a diagnosis are to predict other manifestations that may suggest some syndrome and to anticipate their management, as well as to perform genetic counseling to parents and affected individuals.


American Journal of Medical Genetics Part A | 2015

Molecular classes in 209 patients with Prader–Willi or Angelman syndromes: Lessons for genetic counseling

Víctor Faundes; Lorena Santa María; Solange Aliaga; Bianca Curotto; Ángela Pugin; María Angélica Alliende

Conflict of Interest: None Correspondence to: Dr. Vı́ctor Faundes, Laboratorio de Genética y Enfermedades Metabólicas, Instituto de Nutrición y Tecnologı́a de los Alimentos (INTA), Universidad de Chile, Av. El Lı́bano 5524, P.O. 7830490, Santiago, Chile. E-mail: [email protected] Article first published online in Wiley Online Library (wileyonlinelibrary.com): 6 October 2014 DOI 10.1002/ajmg.a.36801 TO THE EDITOR:


Molecular Syndromology | 2016

Distal 7q11.23 Duplication, an Emerging Microduplication Syndrome: A Case Report and Further Characterisation

Víctor Faundes; Lorena Santa María; Paulina Morales; Bianca Curotto; María M. Parraguez

Chromosome 7q11.23 duplication syndrome is a well-recognised syndrome which involves the duplication of the same genes located in the Williams-Beuren critical region. However, in 2010, 4 patients were reported with a microduplication only in the HIP1 and YWHAG genes. We refer to this as a distal 7q11.23 duplication (dup7q11.23D). Here, we report the fifth de novo patient with dup7q11.23D, whose symptoms may be explained by YWHAG overexpression as was demonstrated recently in mice and obese patients. Finally, further studies will be necessary to delineate this emerging microduplication syndrome.


Biological Research | 2008

Olfactory or auditory stimulation and their hedonic valúes differentially modulate visual working memory

Ana M Donoso; Víctor Faundes; Felipe Falcon; Paulina Esparza; Pedro Maldonado

Working memory (WM) designates the retention of objects or events in conscious awareness when these are not present in the environment. Many studies have focused on the interference properties of distracter stimuli in working memory, but these studies have mainly examined the influence of the intensity of these stimuli. Little is known about the memory modulation of hedonic content of distracter stimuli as they also may affect WM performance or attentional tasks. In this paper, we have studied the performance of a visual WM task where subjects recollect from five to eight visually presented objects while they are simultaneously exposed to additional - albeit weak- auditory or olfactory distracter stimulus. We found that WM performance decreases as the number of Items to remember increases, but this performance was unaltered by any of the distracter stimuli. However, when performance was correlated to the subjects perceived hedonic values, distracter stimuli classified as negative exhibit higher error rates than positive, neutral or control stimuli. We demonstrate that some hedonic content of otherwise neutral stimuli can strongly modulate memory processes.


European Journal of Medical Genetics | 2014

Raine syndrome: An overview

Víctor Faundes; Silvia Castillo-Taucher; Patricio Gonzalez-Hormazabal; Kate Chandler; Andrew H. Crosby; Barry A. Chioza


Biological Theory | 2010

Biological basis of human mate choice: the triple A theory

Víctor Faundes; Andrea Pardo


Neurologia | 2017

Clinical, molecular, and pharmacological aspects of FMR1-related disorders ☆

Ángela Pugin; Víctor Faundes; L. Santa María; Bianca Curotto; Solange Aliaga; Isabel Salas; Paula Soto; Paulina Bravo; M.I. Peña; María Angélica Alliende


Genetics Research | 2016

FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.

Lorena Santa María; Solange Aliaga; Víctor Faundes; Paulina Morales; Ángela Pugin; Bianca Curotto; Paula Soto; M. Ignacia Peña; Isabel Salas; M. Angélica Alliende

Collaboration


Dive into the Víctor Faundes's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge